Now also in Switzerland, home of big Pharma @Roche and ⁦@Novartis,⁩ exorbitant medicines prices and the lack of transparency around R&D cost and pricing are becoming a hot topic of societal debate ⁦@PublicEyeComms⁩ ⁦@MSF_access⁩

Medicines shouldn’t be a luxury